Results 221 to 230 of about 256,813 (405)

Allogeneic Hematopoietic Stem-Cell Transplantation for Myelodysplastic Syndrome

open access: yesHematology, 2010
Abstract Transplantation is the only known cure for myelodysplastic syndrome (MDS). While some comparative analyses have demonstrated early transplantation to be the preferred strategy for all MDS patients, many of these analyses are biased.
openaire   +3 more sources

Toxoplasmosis, a Severe Complication in Allogeneic Hematopoietic Stem Cell Transplantation: Successful Treatment Strategies during a 5-Year Single-Center Experience

open access: bronze, 2001
E. Roemer   +9 more
openalex   +1 more source

Barriers to Hematopoietic Stem Cell Transplant Among Caregivers and Adolescents With Sickle Cell Disease

open access: yesPediatric Blood &Cancer, EarlyView.
ABSTRACT Background Hematopoietic stem cell transplantation (HSCT) is a curative treatment for sickle cell disease (SCD). However, barriers exist that prevent access to this treatment modality. Methods An IRB‐approved mixed‐method survey of barriers to HSCT in SCD was given to parents, caregivers, and adolescents obtaining care at the Children's of ...
Chibuzo Ilonze   +4 more
wiley   +1 more source

Ridge, lasso, and elastic-net estimations of the modified Poisson and least-squares regressions for binary outcome data [PDF]

open access: yesarXiv
Logistic regression is a standard method in multivariate analysis for binary outcome data in epidemiological and clinical studies; however, the resultant odds-ratio estimates fail to provide directly interpretable effect measures. The modified Poisson and least-squares regressions are alternative standard methods that can provide risk-ratio and risk ...
arxiv  

Long-term results favor allogeneic over autologous hematopoietic stem cell transplantation in patients with refractory or recurrent indolent non-Hodgkin’s lymphoma [PDF]

open access: bronze, 2003
Chitra Hosing   +8 more
openalex   +1 more source

A single‐arm feasibility study protocol for a multiphasic multimodal exercise prehabilitation intervention in individuals receiving allogeneic stem cell transplant

open access: yesPM&R, EarlyView.
Abstract Background Allogeneic hematopoietic stem cell transplantation (allo‐HSCT) can be a life‐saving treatment for individuals diagnosed with acute leukemia. However, allo‐HSCT can lead to adverse effects, such as reduced physical function. Exercise has demonstrated benefits in post‐allo‐HSCT recovery, but feasibility issues persist in tailored ...
Chad W. Wagoner   +7 more
wiley   +1 more source

Human CD141+ dendritic cells: A unique tolerogenic subset inducing immune tolerance in systemic lupus erythematosus patients

open access: yesRheumatology &Autoimmunity, EarlyView.
Peripheral blood mononuclear cells were isolated from 12 systemic lupus erythematosus (SLE) patients and 12 healthy controls. The number and function of peripheral blood CD141+ dendritic cells (DCs) were compared between patients and controls. Moreover, the tolerogenic properties of CD141+ and CD1c+ DCs were compared in SLE patients.
Xiaodong Qin   +4 more
wiley   +1 more source

Hetrombopag: A promising thrombopoietin receptor agonist for the treatment of primary and secondary immune thrombocytopenia

open access: yesRheumatology &Autoimmunity, EarlyView.
This review seeks to provide a thorough synthesis of the existing literature on the role of thrombopoietin receptor agonists in the treatment of primary and secondary immune thrombocytopenia, with particular emphasis on the compound Hetrombopag. Abstract Immune thrombocytopenia (ITP) is a rare autoimmune disorder characterized by a platelet count below
Jiaqi Hu   +8 more
wiley   +1 more source

Home - About - Disclaimer - Privacy